
chromeOS Flex Comes To My Rescue For Free. It Can Do The Same For You.
My nine-computer odyssey started around mid-April. The Chromebook I'd been using as my everyday laptop for two years suddenly broke. So I ordered a replacement. After two days, the new machine started going bonkers – as if it was possessed. The keys looked like they were actively pressing things on the screen. At first, I assumed a key was stuck down. After closely examining the keyboard though, I realized that wasn't the issue. Assuming it was software-related, I rebooted the machine. The next day, I not only had the same issue but this time it jumped into my email program and started mass-deleting emails right before my eyes. Like in a horror movie. Which is especially odd because the email program does not allow you to do that manually. I immediately powered down the machine, only to later discover that 200-some emails had been permanently and mysteriously deleted. A Chrome expert ultimately checked the machine and suspected it was caused by a Chrome extension in the browser. Whatever. Machine No. 2 was long gone by then, back to the manufacturer.
In desperation, I tried using a brand-new Windows 11 laptop (Computer 3). Haven't used Windows in a decade and was quickly reminded why. It took two or three steps to accomplish anything that takes one step on a Chromebook. That doesn't sound like a big deal, until you're doing these steps every day all day. It adds up quickly. So I returned the laptop.
I then converted my son's old Windows laptop (Computer 4) to a Chromebook by installing chromeOS flex on it. This is a free program that I encourage anyone to try who is about to throw out an old Windows or Mac machine. It will revive the computer into a fast, useful existence. Well, most of the time. The laptop soon started doing the same thing as the other machine – with the uncontrollable cursor. But this time the cause was a cracked screen. Apparently the computer misinterpreted the screen crack as me pressing down on the touchscreen, which would override where I was trying to place the cursor. So I wiped the PC clean and donated it.
Then a friend graciously volunteered to give me two old Macs (Computers 5 and 6) to convert to chromeOS flex. I'd done it once before for a Macbook Pro, and it worked great. But for these two machines, it failed. The Macbook Air didn't have enough memory to support the job, while the iMac was able to take the software but it had no Bluetooth and another broken internal part. Six machines down, at this point.
I borrowed my wife's Chromebook (Computer 7) for just a week, and vowed to just go buy a new model (Computer 8). I did, and even though it was billed as an upscale model, I found the screen to be simply awful. To make matters worse, every video loaded up super slow. Returned it. And then finally, my same friend found an old laptop (Computer 9) at his office that had gone unused the last few years. I was able to install chromeOS flex on that and it's been a winner. In fact, I think it works better than any of the actual Chromebooks I've used through time. Maybe because its specs are better. This one is a keeper.
Which is why I'm a huge advocate of chromeOS flex. Converting your old machine is fast and easy. Seriously it does all the work, taking about five minutes to remove everything off your old machine and install a cloud-based operating system that's secure and easy to manage. As Google points out in its marketing of the software, it's a great way to breathe new life into your existing devices. Once it's installed, you'll be able to boot up your machine in six seconds. It performs automatic background updates, and it won't slow down over time. You'll be astounded at how your old laptop that could barely get on the web is suddenly surfing through like a brand new, high-end machine. As I found out, not every machine is compatible with it but most are. You can even try it on your old machine before permanently installing it.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Medscape
12 minutes ago
- Medscape
Digital Twins: Medicine's New Crystal Ball?
Digital twins are rapidly emerging as powerful tools in personalized medicine and beyond. In healthcare, they serve as virtual representations of a patient's body, body parts, specific organs, and systems, such as the circulatory and nervous systems. Functional modeling of the state and behavior of the body or its components has the potential to provide information for clinical and research applications. The goal is to simulate how an organ, system, or even the entire body responds to stimuli and circumstances of clinical relevance to the patient, thereby deriving useful conclusions. These models may be descriptive, predictive, prescriptive, or even generative, capable of filling in missing or unavailable data. A central challenge is accurately replicating the physicochemical, physiological, anatomical, and, when needed, psychological attributes relevant to each specific use case. Building clinically useful digital twins depends on integrating diverse data sources, which is a technically complex task. However, when successful, it enables a dynamic 'dialogue' with the model to evaluate its current state, forecast evolution, and simulate responses to interventions such as therapies. It is important to emphasize that digital twin simulations are tailored to individual patients — they do not represent a generic or archetypal patient but instead aim to create a personalized model for a specific individual. One example is a project led by the Spanish National Cancer Research Centre (CNIO), which is developing digital twins of women with advanced cancer using artificial intelligence. This initiative, titled 'High-Definition Oncology in Women's Cancer,' is part of the Precision Medicine Infrastructure Associated With Science and Technology program. These digital twins consist of multiple layers of information integrated into a single model that reflects reality for a specific application. In the aforementioned project, a wide range of data were incorporated into the digital twin models, spanning tumor metabolism, gene and protein expression, physiological indicators such as circadian rhythms, heart rate, and physical activity, emotional well-being, and conventional clinical data from diagnostics to treatment protocols. Adding more 'layers' of information enhances the model complexity and accuracy, enabling incremental improvements and expanded functionality. A notable innovation in this case is the biological clock model developed by the CNIO, which estimates a patient's biologic age. This can help assess whether biologic aging accelerates or slows during disease progression, providing insight into the effect of treatment. This may guide clinicians in adjusting treatment intensity or modifying therapeutic combinations according to the patient's evolving biologic state. The layers of information used and their integration are key aspects of each type of digital twin, ensuring that it is not only functional but also clinically relevant. In many ways, digital twins serve as 'maps,' both literal and figurative. In the most direct sense, they can guide the planning of physical interventions such as surgical procedures. Broader Applications In addition to simulating the effects of therapies, digital twins can model the natural progression of diseases and support long-term care planning. They may help anticipate the onset of certain conditions, particularly hereditary diseases, when risk factors are present but symptoms have yet to appear. These models offer valuable tools for proactive risk prevention and management. In the context of prevention, the ability to present a stronger, data-driven case — even if derived from simulations — could help persuade patients and improve adherence to preventive care guidelines. Integration With Medical Devices From a certain perspective, digital twins resemble a technology-driven 'crystal ball.' Once refined, these models could allow clinicians to explore alternative therapeutic scenarios and identify the most effective treatment strategies. This minimizes reliance on trial and error, enabling faster data-driven decisions in a controlled simulation environment, a kind of clinical sandbox. A key area of synergy lies between the digital twins and medical devices. Wearable technologies, for instance, can supply real-time or periodic health data that dynamically update a patient's digital twin. Conversely, digital twins can enhance the medical device field by enabling the optimization of device configurations or implant placements. Their integration into the body and potential physiological effects can be modeled and simulated in advance, allowing for more precise and personalized interventions. These models also help to synthesize and manage large volumes of complex data. By serving as intelligent filters, they reduce the cognitive load on clinicians, offering clear visualizations and simulations that support more confident decision-making, especially in complex or uncertain clinical situations. Applications and Regulatory Considerations Digital twins hold promise across a wide range of medical applications, from early diagnosis, prognosis, and personalized therapy selection to treatment monitoring and relapse prevention. In fields such as neurology, cardiology, and oncology, these models have already shown potential. Digital twins have already been applied in neurology, cardiology, and oncology. Focusing on Spain-based developments, two recent advances featured by Univadis Spain , a Medscape Network platform, stand out: One involves using digital twins for research on the human brain to uncover mechanisms linked to psychosis remission, and the other demonstrates the use of digital twin improvements in the diagnosis of premature ventricular contractions. While the field is evolving rapidly, it remains in its early stages. Although technical hurdles and regulatory complexities are expected, the long-term potential is significant. Digital twins could enable faster and safer evaluations of multiple treatment paths and support virtual experimentation in a risk-free environment. One major challenge is clinical validation. Digital twins must be tested with real-world longitudinal data and demonstrate that their predictions provide added value compared to current clinical guidelines. Equally crucial is the development of interoperable, cross-border data infrastructure that enables scalable, coordinated adoption across healthcare systems worldwide. A final and crucial aspect to consider is data privacy, ownership, and ethical use of digital twins. Beyond the data itself, fundamental questions arise about digital twin models: Who owns a person's digital twin? Should these models be transferable, and if so, under what conditions? Informed consent is central to addressing these issues and ensuring the responsible use of digital twin technologies in clinical practice. The use of digital twins in clinical trials is already being explored, and their potential extends further to medical training and patient education, particularly in explaining therapeutic options. As technology evolves, the range of future applications continues to expand.
Yahoo
16 minutes ago
- Yahoo
Why OneSpan (OSPN) Outpaced the Stock Market Today
In the latest trading session, OneSpan (OSPN) closed at $17.49, marking a +1.75% move from the previous day. The stock exceeded the S&P 500, which registered a gain of 0.83% for the day. At the same time, the Dow added 0.77%, and the tech-heavy Nasdaq gained 1.02%. Shares of the internet security company have appreciated by 7.5% over the course of the past month, underperforming the Computer and Technology sector's gain of 8.25%, and outperforming the S&P 500's gain of 4.99%. The investment community will be closely monitoring the performance of OneSpan in its forthcoming earnings report. The company is predicted to post an EPS of $0.27, indicating a 12.9% decline compared to the equivalent quarter last year. Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $1.45 per share and revenue of $0 million. These totals would mark changes of +9.85% and 0%, respectively, from last year. Investors should also note any recent changes to analyst estimates for OneSpan. These recent revisions tend to reflect the evolving nature of short-term business trends. As a result, upbeat changes in estimates indicate analysts' favorable outlook on the business health and profitability. Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To utilize this, we have created the Zacks Rank, a proprietary model that integrates these estimate changes and provides a functional rating system. The Zacks Rank system, stretching from #1 (Strong Buy) to #5 (Strong Sell), has a noteworthy track record of outperforming, validated by third-party audits, with stocks rated #1 producing an average annual return of +25% since the year 1988. Within the past 30 days, our consensus EPS projection remained stagnant. As of now, OneSpan holds a Zacks Rank of #3 (Hold). In terms of valuation, OneSpan is currently trading at a Forward P/E ratio of 11.85. For comparison, its industry has an average Forward P/E of 28.74, which means OneSpan is trading at a discount to the group. The Internet - Software industry is part of the Computer and Technology sector. This industry currently has a Zacks Industry Rank of 46, which puts it in the top 19% of all 250+ industries. The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Don't forget to use to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report ONESPAN INC (OSPN) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
17 minutes ago
- Yahoo
SentinelOne (S) Exceeds Market Returns: Some Facts to Consider
SentinelOne (S) closed at $18.45 in the latest trading session, marking a +1.77% move from the prior day. This move outpaced the S&P 500's daily gain of 0.83%. On the other hand, the Dow registered a gain of 0.77%, and the technology-centric Nasdaq increased by 1.02%. Shares of the cybersecurity provider witnessed a gain of 0.89% over the previous month, trailing the performance of the Computer and Technology sector with its gain of 8.25%, and the S&P 500's gain of 4.99%. The upcoming earnings release of SentinelOne will be of great interest to investors. It is anticipated that the company will report an EPS of $0.03, marking a 200% rise compared to the same quarter of the previous year. In the meantime, our current consensus estimate forecasts the revenue to be $242.02 million, indicating a 21.65% growth compared to the corresponding quarter of the prior year. Looking at the full year, the Zacks Consensus Estimates suggest analysts are expecting earnings of $0.2 per share and revenue of $997.27 million. These totals would mark changes of +300% and +21.4%, respectively, from last year. Investors should also note any recent changes to analyst estimates for SentinelOne. These recent revisions tend to reflect the evolving nature of short-term business trends. Consequently, upward revisions in estimates express analysts' positivity towards the business operations and its ability to generate profits. Research indicates that these estimate revisions are directly correlated with near-term share price momentum. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model. The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 1.11% higher. SentinelOne is currently a Zacks Rank #3 (Hold). Investors should also note SentinelOne's current valuation metrics, including its Forward P/E ratio of 90.95. This indicates a premium in contrast to its industry's Forward P/E of 75.56. The Security industry is part of the Computer and Technology sector. With its current Zacks Industry Rank of 34, this industry ranks in the top 14% of all industries, numbering over 250. The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1. Don't forget to use to keep track of all these stock-moving metrics, and others, in the upcoming trading sessions. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report SentinelOne, Inc. (S) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research 擷取數據時發生錯誤 登入存取你的投資組合 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤 擷取數據時發生錯誤